Overture Life CEO and leadership

Mart?n Varsavsky is a CEO & President at Overture Life.

Chief Innovation officer and co-founder @ Overture Life. Founded Reprogenetics, Recombine, Phosphorus, MedAnswers, Overture Life, Rosa Scientific, HoMu Health Ventures. Professor Yale University, Dept Ob/Gyn. Founded Reprogenetics in 2001 with Jacques Cohen, the first commercial lab to offer Preimplantation Genetic testing (PGT) for couples undegoing infertility treatment or carriers of a genetic disease, to help them choose the best embryos with the highest chance to produce a viable pregnancy. We developed the first PGT test to screen against aneuploid (abnormal) embryos. Together with Alex Bisignano I later founded Recombine, a genomics company providing carrier screening for hundreds of genetic diseases for couples before attempting conception. Both Reprogenetics and Recombine were bough by Cooper companies and I became the CSO of CooperGenomics.I have published over 260 peer reviewed publications in the field of reproductive genetics.In 2013 I co-founded MedAnswers with CEO Alice Crisci, a digital health platform for the infertility field, connecting patients with specialists.Phosphorus was founded in 2016 as a spin-off of Recombine and is focused in offering genomics software as a service for laboratories and hospitals.In December 2017 I joined Martin Varsavsky and Joson Horcajadas as co-founder of Overture Life, backed by Khosla Ventures and Felicis, with the intention of revolutionizing fertility treatment and make it more efficient, accesible and affordable.I am currently in the board of advisors of Overture Life, Phosphorus, MedAnswers, Homu Inventis, Aggio, Rosa Scientific, FemCellDX.Specialties: Preimplantation Genetic Testing (PGT); Reproductive Genetics; Reproductive Medicine, Genomics; Recurrent Pregnancy Loss; Product development; management;

Jose Horcajadas is a CSO at Overture Life and is based in Sevilla Area, Spain. He has worked as Director de laboratorio at Fundación IVI, Researcher at Aragon I+D, and Chief Scientific Officer at iGenomix. José works or has worked as Associate Professor at Universidad Pablo de Olavide and Chief Scientific Officer at Recombine-EU. He attended Institute of Biomedical Research of Madrid, Universidad Autónoma de Madrid between 1988 and 1993, and the Universidad.

Jesús Mejía González is a Chief Legal Counsel at Overture Life, Investment Commitee at MVB Fund, and In-House Counsel (Martin Varsavsky´s holding company) at Jazzya Investments and is based in Madrid, Madrid Province, Spain. He has worked as General Counsel at Fon and Corporate/IP Lawyer at Garrigues. Jesús attended Universidad Autónoma de Madrid between 1999 and 2005 and Georgetown Preparatory School between 1995 and 1999.

Mart?n Varsavsky is a CEO & President at Overture Life.

Chief Innovation officer and co-founder @ Overture Life. Founded Reprogenetics, Recombine, Phosphorus, MedAnswers, Overture Life, Rosa Scientific, HoMu Health Ventures. Professor Yale University, Dept Ob/Gyn. Founded Reprogenetics in 2001 with Jacques Cohen, the first commercial lab to offer Preimplantation Genetic testing (PGT) for couples undegoing infertility treatment or carriers of a genetic disease, to help them choose the best embryos with the highest chance to produce a viable pregnancy. We developed the first PGT test to screen against aneuploid (abnormal) embryos. Together with Alex Bisignano I later founded Recombine, a genomics company providing carrier screening for hundreds of genetic diseases for couples before attempting conception. Both Reprogenetics and Recombine were bough by Cooper companies and I became the CSO of CooperGenomics.I have published over 260 peer reviewed publications in the field of reproductive genetics.In 2013 I co-founded MedAnswers with CEO Alice Crisci, a digital health platform for the infertility field, connecting patients with specialists.Phosphorus was founded in 2016 as a spin-off of Recombine and is focused in offering genomics software as a service for laboratories and hospitals.In December 2017 I joined Martin Varsavsky and Joson Horcajadas as co-founder of Overture Life, backed by Khosla Ventures and Felicis, with the intention of revolutionizing fertility treatment and make it more efficient, accesible and affordable.I am currently in the board of advisors of Overture Life, Phosphorus, MedAnswers, Homu Inventis, Aggio, Rosa Scientific, FemCellDX.Specialties: Preimplantation Genetic Testing (PGT); Reproductive Genetics; Reproductive Medicine, Genomics; Recurrent Pregnancy Loss; Product development; management;

Chief Innovation officer and co-founder @ Overture Life. Founded Reprogenetics, Recombine, Phosphorus, MedAnswers, Overture Life, Rosa Scientific, HoMu Health Ventures. Professor Yale University, Dept Ob/Gyn. Founded Reprogenetics in 2001 with Jacques Cohen, the first commercial lab to offer Preimplantation Genetic testing (PGT) for couples undegoing infertility treatment or carriers of a genetic disease, to help them choose the best embryos with the highest chance to produce a viable pregnancy. We developed the first PGT test to screen against aneuploid (abnormal) embryos. Together with Alex Bisignano I later founded Recombine, a genomics company providing carrier screening for hundreds of genetic diseases for couples before attempting conception. Both Reprogenetics and Recombine were bough by Cooper companies and I became the CSO of CooperGenomics.I have published over 260 peer reviewed publications in the field of reproductive genetics.In 2013 I co-founded MedAnswers with CEO Alice Crisci, a digital health platform for the infertility field, connecting patients with specialists.Phosphorus was founded in 2016 as a spin-off of Recombine and is focused in offering genomics software as a service for laboratories and hospitals.In December 2017 I joined Martin Varsavsky and Joson Horcajadas as co-founder of Overture Life, backed by Khosla Ventures and Felicis, with the intention of revolutionizing fertility treatment and make it more efficient, accesible and affordable.I am currently in the board of advisors of Overture Life, Phosphorus, MedAnswers, Homu Inventis, Aggio, Rosa Scientific, FemCellDX.Specialties: Preimplantation Genetic Testing (PGT); Reproductive Genetics; Reproductive Medicine, Genomics; Recurrent Pregnancy Loss; Product development; management;